交聯化羊膜做為生醫材料之方法

Translated title of the contribution: Method for using crosslinked amniotic membrane as biomedical material

Jan-Kan Chen (Inventor), CHENCHI TSAI (Inventor), HUI-KANG MA (Inventor)

Research output: Patent

Abstract

The present invention is a method for using crosslinked amniotic membrane, which utilizes EDC to crosslink thereby, as biomedical material. Disclosed is more resistant to protease, and furthermore, crosslinks specific extracellular matrix, such as heparin, by the functional group for crosslink. In addition, utilizing the affinity between these extracellular matrix and specific growth factors, amniotic membrane turns into carriers overexpressing some kind of growth factors for treating specific disease.
Translated title of the contributionMethod for using crosslinked amniotic membrane as biomedical material
Original languageChinese (Traditional)
IPCA61K 35/50(2015.01); A61L 31/12(2006.01); A61P 31/00(2006.01); A61F 9/02(2006.01)
StatePublished - 16 04 2007

Bibliographical note

公開公告號: 2.00714286E8
Announcement ID: 2.00714286E8

Fingerprint

Dive into the research topics of 'Method for using crosslinked amniotic membrane as biomedical material'. Together they form a unique fingerprint.

Cite this